Clinical Trials for Stomach Cancer

201102096

Prospective Registry Study of Neoadjuvant Therapy in Conjunction with Liver Transplantation for Cholangiocarcinoma Phase N/A Principal Investigator Chapman, Will Disease Site Liver; Other Digestive Organ Learn more about this study at: clinicaltrials.gov

201107221

Tissue and Blood Acquisition for Genomic Analysis and Collection of Health Information for Patients with Gastrointestinal Cancers Phase N/A Principal Investigator Tan, Benjamin Disease Site Colon; Esophagus; Ill-Defined Sites; Larynx; Liver; Other Digestive Organ; Pancreas;…

201410102

Positron emission tomography (PET) imaging of poly(ADP-ribose) polymerase (PARP) activity in cancer Phase Early Phase I Principal Investigator Dehdashti, Farrokh Disease Site Colon; Lip, Oral Cavity and Pharynx; Liver; No Disease; Pancreas; Rectum; Unknown Sites…

201709013

A Multicenter Pilot Study of Nivolumab with Drug Eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma Phase Early Phase I Principal Investigator Tan, Benjamin Disease Site Liver Learn more about this study at:…

201803092

A Phase II Study of Proton Beam Therapy in the Treatment of Esophageal Cancer Phase II Principal Investigator Badiyan, Shahed Disease Site Esophagus Learn more about this study at: clinicaltrials.gov

201805016

A Phase II Multi-Center Study of SM-88 in Subjects with Pancreatic Cancer Whose Disease Has Progressed or Recurred after/on First Line Chemotherapy Phase II/III Principal Investigator Tan, Benjamin Disease Site Pancreas Learn more about this…

201806007

A phase I/II study to evaluate the tolerability and efficacy of BMS-813160 (CCR2/5 inhibitor) with nivolumab and gemcitabine and nab-paclitaxel in borderline resectable and locally advanced pancreatic ductal adenocarcinoma (PDAC) Phase I/II Principal Investigator Lim,…

201807099

Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy Phase I Principal Investigator Dehdashti, Farrokh Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

201808122

Randomized, Double-blinded Phase III Study of Cabozantinib versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus Phase III Principal Investigator Trikalinos, Nikolaos Disease Site Lung; Pancreas Learn more about this study at:…

201808178

A Phase II study of chemotherapy and immune checkpoint blockade with Pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma. Phase II (Cancer Control) Principal Investigator Park, Haeseong Disease Site…

201812139

Prospective phase II Study of Stereotactic MR-guided on-table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Inoperable Locally Advanced Pancreatic Cancer Phase II Principal Investigator Kim, Hyun Disease Site Pancreas Learn more about this…

201901172

Pilot Study of Same-session MR-only Simulation and Treatment with MRI-guided Adaptive Palliative Radiotherapy Phase N/A Principal Investigator Kim, Hyun Disease Site Anus; Bones and Joints; Brain and Nervous System; Breast; Cervix; Colon; Corpus Uteri; Esophagus;…

201903120

A Phase I Open Label, Clinical Trial Evaluating the Safety and Anti-tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha-fetoprotein (AFPc332T) in HLA-A2 Positive Subjects with Advanced Hepatocellular Carcinoma (HCC) Phase I…

201905167

A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi- Regional, International Study of Durvalumab in Combination with Gemcitabine plus Cisplatin versus Placebo in Combination with Gemcitabine plus Cisplatin for Patients with First-Line Advanced Biliary Tract Cancers (TOPAZ-1)…

201908124

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy Phase I Principal Investigator Gillanders, William Disease Site…

201908202

A Phase 2/3 Trial to Evaluate Margetuximab in Combination with INCMGA00012 and Chemotherapy or MGD013 and Chemotherapy in Patients with Metastatic or Locally Advanced, Treatment-naïve, HER2-Positive Gastric or Gastroesophageal Junction Cancer Phase II/III Principal Investigator…

201909019

Phase I Study of Radiation Dose Intensification with Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer Phase I Principal Investigator Badiyan, Shahed Disease Site Esophagus Learn more about…

201909063

A Phase I, First-In-Human, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors Phase I Principal Investigator Pedersen, Katrina Disease Site Colon; Other Digestive Organ; Rectum; Stomach Learn more…

201911054

Phase II Study of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Previously Treated Advanced Biliary Tract Cancer (NAPOLI-2) Phase II Principal Investigator Pedersen, Katrina Disease Site Other Digestive Organ Learn more about this study at: clinicaltrials.gov

201911059

MR-guided Pre-operative RT in Gastric Cancer Phase N/A Principal Investigator Kim, Hyun Disease Site Stomach Learn more about this study at: clinicaltrials.gov

201911080

A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-foot Skin Reaction in Cancer Patients Study Number OQL011B002 Phase II Principal Investigator Anadkat, Milan Disease Site Acute Myeloid Leukemia…

201911155

A Phase 1 Study to Evaluate the Safety and Tolerability of AB680 Combination Therapy in Participants with Gastrointestinal Malignancies Phase I (Cancer Control) Principal Investigator Lim, Kian-Huat Disease Site Metastatic Disease; Pancreas Learn more about…

201911159

PRECISION PROMISE PLATFORM TRIAL FOR METASTATIC PANCREATIC CANCER Phase III (Cancer Control) Principal Investigator Lim, Kian-Huat Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

201912097

A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid Tumors Phase I Principal Investigator Adkins, Douglas Disease Site Kidney; Larynx; Lip, Oral…

202001128

A phase I/Ib, open-label, multi-center, study of KAZ954 as a single agent and in combination with Spartalizumab, NZV930 and NIR178 in patients with advanced solid tumors Phase Early Phase I (Cancer Control) Principal Investigator Park,…

202002190

A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA) Phase III Principal Investigator Park, Haeseong Disease Site Esophagus; Metastatic Disease; Stomach Learn more about this study…

202006133

A phase 1b/2 dose escalation and expansion study of tucatinib in combination with trastuzumab and oxaliplatin-based chemotherapy for HER2+ gastrointestinal cancers Phase I/II Principal Investigator Park, Haeseong Disease Site Colon; Esophagus; Other Digestive Organ; Rectum;…

202006156

A Phase 2b, open-label, single-arm study of ZW25 monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers Phase II Principal Investigator Tan, Benjamin Disease Site Other Digestive Organ Learn more about this study…

202007090

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer Phase III Principal Investigator Hawkins, William Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

202007122

Blood acquisition for circulating tumor DNA (ctDNA) analysis for patients undergoing peptide receptor radionuclide therapy (PRRT) in patients with metastatic unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Phase N/A Principal Investigator Trikalinos, Nikolaos Disease Site Metastatic Disease;…

202007167

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB WITH OR WITHOUT TIRAGOLUMAB (ANTI-TIGIT ANTIBODY) IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA Phase III Principal Investigator Park, Haeseong Disease Site Esophagus…

202007173

Cabozantinib in high grade neuroendocrine neoplasms Phase II Principal Investigator Trikalinos, Nikolaos Disease Site Colon; Lung; Other Digestive Organ; Other Endocrine System; Other Respiratory and Intrathoracic Organs; Pancreas; Small Intestine Learn more about this study…

202009002

A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT) Phase II Principal Investigator Lim, Kian-Huat Disease Site Pancreas…

202011019

Targeting pancreatic cancer with sodium glucose transporter 2 (SGLT2) inhibition Phase I Principal Investigator Lim, Kian-Huat Disease Site Metastatic Disease; Pancreas Learn more about this study at: clinicaltrials.gov

202011125

Testing the immunologic effects of CDX-301 and CDX-1140 in resectable pancreatic cancer patients Phase II Principal Investigator Hawkins, William Disease Site Pancreas Learn more about this study at: clinicaltrials.gov

202012018

Phase II study of short course FOLFOX chemotherapy with either Nivolumab or Nivolumab + Radiation in the first line treatment of metastatic or unresectable gastroesophageal cancers (BMS Protocol CA209-76L) Phase II Principal Investigator Park, Haeseong…

202101058

Phase III Randomized Trial of Proton Beam Therapy(PBT) versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer Phase III Principal Investigator Badiyan, Shahed Disease Site Esophagus Learn more about this study at:…

202102071

A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma Phase II/III Principal Investigator Park, Haeseong Disease Site Esophagus Learn more about this study at: clinicaltrials.gov

202105140

Phase 1/1B study of DS-8201a in combination with ATR Inhibition (AZD6738) in advanced solid tumors with HER2 expression (DASH Trial) Phase I Principal Investigator Grierson, Patrick Disease Site Esophagus; Stomach Learn more about this study…

202106061

Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma Phase II Principal Investigator Kim, Hyun Disease Site Pancreas Learn more about this study at: clinicaltrials.gov